biotech

GettyImages_183162370

Large Companies With Fastest Revenue and Earnings Growth in 2015

This year is nearing the halfway mark and analysts are beginning to project their biggest winners and losers on the year. S&P Capital IQ recently released a report regarding the ...
Read Full Story »
biotech

The Most Loved Biotechs of Big Hedge Funds

With such a mixed performance over the past decade, some of us wonder why hedge funds are so revered. Ditto for many of the so-called guru fund managers. Still, investors ...
Read Full Story »
DNA

How to Evaluate a 50% Move in AVEO

When investors see stocks run up 50% or more on a news release, they probably just assume the company is being acquired. AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) saw its shares ...
Read Full Story »
investing

Has MannKind Stock Finally Bottomed Out?

MannKind Corp. (NASDAQ: MNKD) is just about as controversial of a company as you will find today when it comes to biotech and pharma. Its recently launched Afrezza has had ...
Read Full Story »
fda_logo

How Sarepta Short Interest Is Adding to Its Gains

Usually, when biotech companies meet with the U.S. Food and Drug Administration (FDA), their stock goes one of two ways. In the case of Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares ...
Read Full Story »
biotech

Is This the End of the Growth Phase for Intercept?

Investors are not too happy with Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) after it released the terms for its most recent clinical trial. Over the course of 2015, shares have nearly ...
Read Full Story »
Sad lonely pensive old senior woman

What This New Trial Means for Eleven Biotherapeutics

Biotechs are generally riskier companies. A single failed trial can make or break a company. Eleven Biotherapeutics Inc. (NASDAQ: EBIO) felt this pressure when it released its most recent clinical ...
Read Full Story »
Prescription drugs

The 5 Winners and Losers From ASCO Presentations

With the American Society of Clinical Oncology (ASCO) annual meeting just two weeks away, investors, doctors and cancer patients are anxiously awaiting some of the key presentations and abstracts that ...
Read Full Story »
research

Analyst Issues 5 Potential Biotech Buyout Candidates

We have said it before, and we will stress it once again, one of the best ways for big pharmaceuticals and biotech companies to grow is through acquisitions. In a ...
Read Full Story »
DNA

Why This Study May Have Saved Pain Therapeutics

Both biotech and pharmaceutical companies have a mission to make life better for everyone through the innovation and production of drugs that can save lives. Pain Therapeutics Inc. (NASDAQ: PTIE) ...
Read Full Story »
generic drugs

4 Biotech Stocks Could Have Big Upside Before Russell Index Changes

Typically when we cover index rebalancing or reconstitutions, they are happening within a few days of when our story is posted. Investors may have a huge head start as, even ...
Read Full Story »
biotech

Short Sellers Start to Get Nervous on Biotech

The short interest data are out for the April 30 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
145922793

GSK Takes Aim at AIDS/HIV Cure, Funding Company With University of North Carolina at Chapel Hill

Any time that you hear about new drugs and medical treatments, they tend to be around ongoing treatments rather than cures. And when it comes to AIDS and HIV, the ...
Read Full Story »
Biotechnology word cloud

4 Speculative Biotechs With Huge Analyst Targets

Investors have been in love with the speculative biotech sector for years now. If there is one group of stocks that can produce returns of 100%, 200% or even ten-baggers, ...
Read Full Story »
penny stack

What to Make of MannKind Earnings

MannKind Corp. (NASDAQ: MNKD) reported its first-quarter financial results after the markets closed Thursday. The biotech company had a net loss of $0.08 in earnings per share (EPS) and no ...
Read Full Story »